Accipio Ax™

Provides automatic, rapid, highly accurate slice-level annotation & prioritization of suspected ICH.

MaxQ AI® is ushering in a new era of AI-augmented healthcare through a comprehensive, seamless, and secure platform of patient-level medical diagnostic solutions. We aim to empower care providers around the world to better prioritize life-threatening conditions, such as stroke and head trauma in acute care settings. These solutions will help across the diagnosis, prognosis, and therapeutic pathways; potentially saving lives, improving the quality of care, and lowering healthcare costs. 

MaxQ AI’s software platform is being designed to comprise several AI applications branded under the name ACCIPIO® (meaning “to learn” in Latin). ACCIPIO uses artificial intelligence for the comprehensive, seamless, and secure assessment of non-contrast head CT for intracranial hemorrhage (ICH) prioritization, triage, and annotation.
Accipio Ax* is the second solution of MaxQ AI’s ACCIPIO ICH and Stroke Platform with INSIGHT™ that provides automatic, rapid, highly accurate prioritization and slice-level annotation of suspected ICH. Accipio Ax integrates into a comprehensive, seamless, and secure workflow to augment acute care teams with deep clinical insights and actionable data in minutes. It is CE Marked, TGA Approved, IMOH Approved.

*Accipio Ax™: CE Marked, TGA Approved.  

Key Features

  • Trusted Results: Provides a highly accurate auto-processing of the DICOM adult non-contrast head CT images using artificial intelligence for prioritization and slice-level annotation of suspected intracranial hemorrhage.
  • Powerful Simplicity: Auto-returns rapid case-level summary report with SliceMap™ of all CT images with a suspected intracranial hemorrhage to any DICOM compliant CT terminal or PACS worklist, informing if a suspected hemorrhage has been found.
  • Absolute Zero: Zero clicks to ACCIPIO® results. Zero need to leave workflow. Zero stored PHI. Zero change to original series. No onsite IT integration required. Seamless from the Start™.
  • CE Marked, TGA Approved; U.S. Investigational Use Only*, Not Available for sale in the U.S.
  • ISO 13485 certified manufacturer. GDPR compliant. Supports HIPAA compliance. ISO 27001 Information Management Security certified.
  • *CAUTION- Investigational Device, Limited by Federal Law to Investigational Use.
  • Flexible Deployment, SPAN: Maximum flexibility, rapidly deployed on major OEM CT and PACS, on-premises, and cloud-capable design. Able to grow with your CT and PACS.

 
MaxQ AI Overview US.
The Impact of AI on Stroke Treatment: Interview with Dr. Navdeep Sangha of Kaiser Permanente – US.
MaxQ AI RSNA 2019 Symposium – Highlights of "AI: Delivering on the Promise" US

 

Country availability
Austria Denmark Finland Germany Luxembourg Netherlands Norway Sweden Switzerland United Kingdom Israel Australia

Product line
  • Centricity PACS with Universal Viewer
  • Edison™ Open Orchestrator
Compatible devices
  • Centricity PACS
  • Centricity Universal Viewer
  • Edison Open AI Orchestrator
  • CT Revolution
  • CT Revolution EVO
  • CT Digital
Regional availability
  • Selective EU
  • Selective APAC
  • Selective EGM
Languages
  • English
Product Tags
CTPET/CTPACSNon-GE AppEdison Open AI OrchestratorNeurologyRadiologyStrokeApplicationArtificial Intelligence

More Products Of Interest

Accipio Ix™
Provides automatic identification/detection, notification, acceleration, and prioritization of suspected ICH....Learn more
ClearRead™ CT
ClearRead CT automatically detects and measures properties of solid, part-solid, and ground-glass nodules, suppressing normal structures in chest CTs to reduce nodule search time and improve the accuracy of nodule identification....Learn more
Lunit INSIGHT CXR
AI solution for chest x-ray analysis that detects 9 abnormal radiologic findings with 97-99% accuracy....Learn more